US 10017487
Fused heterocyclic compound
granted A61KA61K31/343A61K31/422
Quick answer
US patent 10017487 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/343, A61K31/422, A61K31/665, A61P